A detailed history of First Long Island Investors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, First Long Island Investors, LLC holds 31,200 shares of NVO stock, worth $3.28 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
31,200
Holding current value
$3.28 Million
% of portfolio
0.3%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $3.71 Million - $4.54 Million
31,200 New
31,200 $3.71 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track First Long Island Investors, LLC Portfolio

Follow First Long Island Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Long Island Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Long Island Investors, LLC with notifications on news.